Dave Bloom - 2018/11/28 0

An independent review of the value, costs and effectiveness of Viaskin Peanut, AR101, and private practice peanut OIT.

Dave Bloom - 2018/02/28 0

Announcements regarding two food allergy therapies that are in or advancing toward clinical trials were made yesterday.

Dave Bloom - 2017/10/12 0

The phase III trial was designed to assess the safety and routine clinical use of Viaskin Peanut.

Dave Bloom - 2017/03/22 1

The study received higher-than-expected patient demand.

Dave Bloom - 2017/03/07 0

The study model used common packaged foods such as cookies, ice cream, and doughnuts as references.

Dave Bloom - 2015/06/30 0

The board overseeing the Phase I study of the milk allergy therapy found no safety concerns.

Dave Bloom - 2015/04/09 0

The Viaskin Peanut patch received the BT designation after a positive Phase IIb trial.

Dave Bloom - 2022/09/23 0

It is unknown how this development will affect the ability of the company to eventually offer Viaskin Peanut as an FDA approved therapy.

Dave Bloom - 2019/08/08 0

DBV Technologies Submits Biologics License Application to FDA for Viaskin Peanut for the Treatment of Peanut Allergy (+4 Articles)

News Wire ~ 3rd Party Press Release - 2025/01/14 0

68.2% of subjects completed the oral food challenge (~12-14 peanut kernels) without meeting stopping criteria, compared to 30.7% at month 12.

viaskin peanut - search results